Matthew Aponte

Matthew Aponte serves as a procurement professional dedicated to acquiring specialized dental laboratory services under federal contracting frameworks. While his official title and agency affiliation are not publicly disclosed, his procurement activity is highly focused, ensuring that critical dental prosthetics, orthodontic appliances, and custom lab-fabricated devices are sourced in compliance with federal acquisition regulations. He plays a pivotal role in advancing the agency’s mission to deliver high-quality oral health solutions by managing the full lifecycle of acquisitions—from requirements development to contract award and administration—ensuring technical specifications align with clinical standards and regulatory compliance. His contractor relationships are exclusively with small businesses, as all awards are issued under full small business set-asides per FAR 19.5. He does not engage with large prime contractors; instead, he cultivates partnerships with niche dental laboratories that possess specialized capabilities in CAD/CAM fabrication, implant-supported prosthetics, and precision casting. These vendors are typically owner-operated enterprises with deep domain expertise in dental materials science and regulatory adherence to ANSI/ADA standards. Aponte maintains a 100% commitment to small business set-asides, consistently directing all procurements to small businesses without preference for specific socioeconomic categories beyond the general small business classification. This reflects a deliberate strategy to maximize participation among micro-enterprises and locally based dental labs, promoting equitable access to federal contracting opportunities without reliance on 8(a), HUBZone, or SDVOSB designations. His technical focus is singularly centered on NAICS 339116—Dental Laboratories—where he procures custom-fabricated dental devices including crowns, bridges, dentures, splints, and orthodontic appliances. His expertise lies in evaluating technical submissions for material composition, biocompatibility, dimensional accuracy, and compliance with FDA and ISO 13485 quality management systems, ensuring that all delivered products meet stringent clinical and safety benchmarks.